What is PCCP (Predetermined change control plan)?

A predetermined change control plan (PCCP) is a section of a device's marketing submission that describes planned modifications, the methods for developing, validating, and implementing them, and an assessment of their impact. Once FDA authorizes the plan, changes made consistent with it do not need a new 510(k) or PMA supplement.

PCCPs have a statutory basis. Section 3308 of the Food and Drug Omnibus Reform Act of 2022 (FDORA), enacted on December 29, 2022, added section 515C to the FD&C Act. Under it, FDA can approve or clear a PCCP for a device, and a change consistent with an authorized PCCP does not require a new premarket notification or PMA supplement. FDA may require the plan to include labeling for safe and effective use as the device changes, notification requirements if the device does not perform as intended, and performance requirements for the changes.

PCCPs for AI-enabled device software

FDA's final guidance on PCCPs for AI-enabled device software functions, in its version dated August 2025, covers devices reviewed through the 510(k), De Novo, and PMA pathways, and the device part of device-led combination products. It recommends that a PCCP describe the planned device modifications, the methodology to develop, validate, and implement them, and an assessment of their impact. FDA encourages sponsors to discuss a proposed PCCP with the agency through the Q-Submission program before filing.

What it means in practice

A PCCP moves change decisions to design time. The team has to know, before the first submission, which changes it expects to make and what evidence will show each one is safe. That pushes real engineering work forward: a retraining pipeline that can be described step by step, a fixed test dataset kept apart from training data, acceptance criteria written in advance, and a way to update labeling when performance changes. Anything outside the plan still goes through the normal 510(k) change analysis.

Example

A company with a machine learning model that triages imaging studies expects to retrain it as more hospitals adopt it. Its PCCP describes the modification (retraining on data from new sites, same intended use, same input types), the protocol (data management rules, the retraining procedure, a held-out test set, and performance thresholds the new model must meet overall and by subgroup), and how it will assess the impact of each update. After authorization, each retraining that follows the protocol can ship without a new submission. Expanding the model to a new body region is not in the plan, so it would need its own submission.